1. Home
  2. IOVA vs USAS Comparison

IOVA vs USAS Comparison

Compare IOVA & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.20

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$4.85

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
USAS
Founded
2007
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
IOVA
USAS
Price
$4.20
$4.85
Analyst Decision
Buy
Strong Buy
Analyst Count
10
2
Target Price
$9.00
$6.50
AVG Volume (30 Days)
14.1M
4.0M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
14.84
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$47.74
$174.68
Revenue Next Year
$40.31
$53.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$0.85
52 Week High
$5.63
$10.50

Technical Indicators

Market Signals
Indicator
IOVA
USAS
Relative Strength Index (RSI) 56.87 43.25
Support Level $2.07 $4.60
Resistance Level $4.35 $5.12
Average True Range (ATR) 0.33 0.34
MACD -0.00 -0.01
Stochastic Oscillator 55.29 24.23

Price Performance

Historical Comparison
IOVA
USAS

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

Share on Social Networks: